Oncoinvent ASA (7BG) Stock Price & News

All values in NOK	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	8.05M	8.05M	4.10M	4.10M
Cost of goods sold	-	-	-	-
Cost of revenue	-	-	-	-
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	19.41M	19.41M	20.55M	20.55M
Operating expense	61.21M	61.21M	38.60M	38.60M
Total operating expenses	61.21M	61.21M	38.60M	38.60M
Operating income	-53.16M	-53.16M	-34.50M	-34.50M
Other non operating income	297.00K	297.00K	1.00K	1.00K
EBT including unusual items	-51.54M	-51.54M	-34.04M	-34.04M
EBT excluding unusual items	-51.54M	-51.54M	-34.04M	-34.04M
Income tax expense	-	-	-	-
Effective tax rate	-	-	-	-
Other operating expenses	40.08M	40.08M	15.50M	15.50M
Net income	-51.54M	-51.54M	-34.04M	-34.04M
Net profit margin	-639.93%	-639.93%	-829.82%	-829.82%
Earnings per share	-	-	-	-
Interest and investment income	1.73M	1.73M	460.50K	460.50K
Interest expense	-	-	-	-
Net interest expenses	1.73M	1.73M	460.50K	460.50K
Depreciation and amortization charges	1.72M	1.72M	2.55M	2.55M
EBITDA	-51.02M	-51.02M	-32.62M	-32.62M
Gain or loss from assets sale	-	-	-	-

Finance